Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial

Annals of Surgery

Volumn 256, Issue 6, 2012, Pages 920-924

  Martelli, Gabriele ^a   Boracchi, Patrizia ^b   Ardoino, Ilaria ^b   Lozza, Laura ^a   Bohm, Silvia ^a   Vetrella, Gaetano ^c   Agresti, Roberto ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Melegnano Hospital   (Italy)

Author keywords

axillary surgery; breast cancer; older patients; randomized trial; tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN;

AGED; ARTICLE; AXILLARY DISSECTION; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; CANCER CONTROL; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; EARLY INTERVENTION; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84870008889     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31827660a8     Document Type: Article

References (23)

1. Tabar L, Yen MF, Vitak B, et al. Mammography service screening and mortality in breast cancer patients:20-year follow-up before and after introduction of screening. Lancet. 2003;361:1405-1410.
2. Halsted WS. The results of radical operations for the cure of cancer of the breast. Ann Surg. 1907;46:1-5.
3. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312:674-681.
4. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-401.
5. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy can avoid axillary dissection in breast cancer patients with clinically negative lymph-nodes. Lancet. 1997;349:1864-1867.
6. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicentric trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006;98:599-609.
7. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-553.
8. Martelli G, Miceli R, Daidone MG, et al. Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol. 2011;18:125-133.
9. Martelli G, Boracchi P, De Palo M, et al. A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after five years of follow-up. Ann Surg. 2005;242:1-6.
10. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-410.
11. Schemper M, Smith T. A note of quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17:343-346.
12. Marubini E, Valsecchi MG. Analysing Survival Data From Clinical Trials and Observational Studies. Chichester, UK: John Wiley & Sons; 1995.
13. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risks. Ann Stat. 1988;16:1141-1154.
14. Fine JP, Gray R. A proportional hazard model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
15. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567-575.
16. Rudenstam CM, Zahrieh D, Forbes JE, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group trial 10-93. J Clin Oncol. 2006;24:337-344.
17. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569-575.
18. Sanghani M, Balk EM, Cady B. Impact of axillary lymph node dissection on breast cancer out come in clinically node negative patients. Cancer. 2009;115:1613-1620.
19. Martelli G, Miceli R, Costa A, et al. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study. Cancer. 2008;112:481-488.
20. Aristei C, Chionne F, Marsella AR, et al. Evaluation of level I and II axillary nodes included in the standard breast tangential fields and calculation of the administered dose: results of a prospective study. Int J radiat Oncol boil Phys. 2001;51:69-73.
21. Clarke MF, Fuller M. Stem cells and cancer: two faces of eve. Cell. 2006;124:1111-1115.
22. Zhang M, Rosen JM. Stem cells in the etiology and treatment of cancer. Curr Opin Genet Dev. 2006;16:60-64.
23. Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer. Ann Oncol. 2009;20:1319-1329.